Community optometrists able to diagnose glaucoma accurately

Article

Community optometrists trained in glaucoma can provide satisfactory decisions regarding diagnosis and initiation of treatment.

Community optometrists trained in glaucoma can provide satisfactory decisions regarding diagnosis and initiation of treatment, according to a report published online ahead of print by the British Journal of Ophthalmology.

Augusto Azuara Blanco and colleagues from the Aberdeen Royal Infirmary and the University of Aberdeen, UK compared the diagnostic abilities of accredited glaucoma optometrists (AGO) with that of routine hospital eyecare against a reference standard of expert opinion, i.e. consultant ophthalmologists with a special interest in glaucoma.

A total of 100 subjects were examined. People suspected of having glaucoma underwent full assessment both in the newly established, optometry led glaucoma management scheme and in a consultant led hospital eye service.

Agreement between the AGO and consultant ophthalmologists was significant at 89%. Agreement regarding the need for treatment was also substantial (88%) whilst the agreement between trainee ophthalmologist and consultant ophthalmologist was moderate (83%).

It was concluded that community optometrists trained in glaucoma are able to offer satisfactory diagnoses and initiation of treatment.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.